Of even greater concern is that CA125 and the more recently approved biomarker human epididymis 4 (HE4) [7] have limited diagnostic and prognostic value with the second most common type of EOC, mucinous ovarian cancer. The gene discussed is MUC16; the disease is mucinous ovarian cancer.